The DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
Temporal Relationship Between Elevation of Epstein-Barr Virus Antibody Titers and Initial Onset of Neurological Symptoms in Multiple Sclerosis
Abstract
CONTEXT: Infection with Epstein-Barr virus (EBV) has been associated with an increased risk of multiple sclerosis (MS), but the temporal relationship remains unclear. OBJECTIVE: To determine whether antibodies to EBV are elevated before the onset of MS. DESIGN, SETTING, AND PARTICIPANTS: Nested case-control study conducted among more than 3 million US military personnel with blood samples collected between 1988 and 2000 and stored in the Department of Defense Serum Repository. Cases were identified as individuals granted temporary or permanent disability because of MS. For each case (n = 83), 2 controls matched by age, sex, race/ethnicity, and dates of blood sample collection were selected. Serial samples collected before the onset of symptoms were available for 69 matched case-control sets. MAIN OUTCOME MEASURES: Antibodies including IgA against EBV viral capsid antigen (VCA), and IgG against VCA, nuclear antigens (EBNA complex, EBNA-1, and EBNA-2), diffuse and restricted early antigens, and cytomegalovirus. RESULTS: The average time between blood collection and MS onset was 4 years (range, <1-11 years). The strongest predictors of MS were serum levels of IgG antibodies to EBNA complex or EBNA-1. Among individuals who developed MS, serum antibody titers to EBNA complex were similar to those of controls before the age of 20 years (geometric mean titers: cases = 245, controls = 265), but 2- to 3-fold higher at age 25 years and older (cases = 684, controls = 282; P<.001). The risk of MS increased with these antibody titers; the relative risk (RR) in persons with EBNA complex titers of at least 1280 compared with those with titers less than 80 was 9.4 (95% confidence interval [CI], 2.5-35.4; P for trend <.001). In longitudinal analyses, a 4-fold increase in anti-EBNA complex or anti-EBNA-1 titers during the follow-up was associated with a 3-fold increase in MS risk (EBNA complex: RR , 3.0; 95% CI, 1.3-6.5; EBNA-1: RR, 3.0; 95% CI, 1.2-7.3). No association was found between cytomegalovirus antibodies and MS. CONCLUSION: These results suggest an age-dependent relationship between EBV infection and development of MS.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
New diagnostic criteria for multiple sclerosis: Guidelines for research protocols
Poser, C. M., Paty, D. W., Scheinberg, L., McDonald, W. I., Davis, F. A., Ebers, G. C., Johnson, K. P., Sibley, W. A., Silberberg, D. H., & Tourtellotte, W. W. (1983) · Annals of Neurology · doi:10.1002/ana.410130302 · Cited by 7,384
(2001) · Statistics for Psychologists · doi:10.4324/9781410605542-11 · Cited by 6,877
The Effect of Infections on Susceptibility to Autoimmune and Allergic Diseases
Bach, J.-F. (2002) · New England Journal of Medicine · doi:10.1056/nejmra020100 · Cited by 2,687
Rickinson, A. (2001) · Virus Research · doi:10.1016/s0168-1702(01)00436-1 · Cited by 2,179
Manual of Clinical Microbiology, 7th ed.
Balows, A. (2000) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/s0732-8893(99)00102-9 · Cited by 1,613
de-Thé, G., Geser, A., Day, N. E., Tukei, P. M., Williams, E. H., Beri, D. P., Smith, P. G., Dean, A. G., Bornkamm, G. W., Feorino, P., et al. (1978) · Nature · doi:10.1038/274756a0 · Cited by 613
Epstein-Barr Virus Antibodies and Risk of Multiple Sclerosis: A Prospective Study
Ascherio, A., Munger, K. L., Lennette, E. T., Spiegelman, D., Hernán, M. A., Olek, M. J., Hankinson, S. E., & Hunter, D. J. (2001) · JAMA · doi:10.1001/jama.286.24.3083 · Cited by 549
Serologic Markers of Epstein–Barr Virus Infection and Nasopharyngeal Carcinoma in Taiwanese Men
Chien, Y.-C., Chen, J.-Y., Liu, M.-Y., Yang, H.-I., Hsu, M.-M., Chen, C.-J., & Yang, C.-S. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa011610 · Cited by 487
Epidemiologic evidence for multiple sclerosis as an infection
Kurtzke, J. F. (1993) · Clinical Microbiology Reviews · doi:10.1128/cmr.6.4.382 · Cited by 472
No one is naive: the significance of heterologous T-cell immunity
Welsh, R. M., & Selin, L. K. (2002) · Nature Reviews Immunology · doi:10.1038/nri820 · Cited by 463
Hodgkin's Disease and Epstein-Barr Virus
Mueller, N., Evans, A., Harris, N. L., Comstock, G. W., Jellum, E., Magnus, K., Orentreich, N., Polk, B. F., & Vogelman, J. (1989) · New England Journal of Medicine · doi:10.1056/nejm198903163201103 · Cited by 445
Systemic lupus erythematosus in adults is associated with previous Epstein-Barr virus exposure
James, J. A., Neas, B. R., Moser, K. L., Hall, T., Bruner, G. R., Sestak, A. L., & Harley, J. B. (2001) · Arthritis & Rheumatism · doi:10.1002/1529-0131(200105)44:5<1122::aid-anr193>3.0.co;2-d · Cited by 390
Epstein-Barr virus and multiple sclerosis
Robinson, W. H., & Steinman, L. (2022) · Science · doi:10.1126/science.abm7930 · Cited by 310
Rubertone, M. V., & Brundage, J. F. (2002) · American Journal of Public Health · doi:10.2105/ajph.92.12.1900 · Cited by 304
An altered immune response to Epstein-Barr virus in multiple sclerosis: A prospective study
Sundström, P., Juto, P., Wadell, G., Hallmans, G., Svenningsson, A., Nyström, L., Dillner, J., & Forsgren, L. (2004) · Neurology · doi:10.1212/01.wnl.0000130496.51156.d7 · Cited by 301
Epstein-Barr Virus in Pediatric Multiple Sclerosis
Alotaibi, S. (2004) · JAMA · doi:10.1001/jama.291.15.1875 · Cited by 280
Henle, W., Henle, G., Andersson, J., Ernberg, I., Klein, G., Horwitz, C. A., Marklund, G., Rymo, L., Wellinder, C., & Straus, S. E. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.2.570 · Cited by 207
Leibowitz, U., Antonovsky, A., Medalie, J. M., Smith, H. A., Halpern, L., & Alter, M. (1966) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.29.1.60 · Cited by 169
Exposure to Infant Siblings During Early Life and Risk of Multiple Sclerosis
Ponsonby, A.-L. (2005) · JAMA · doi:10.1001/jama.293.4.463 · Cited by 166
Multiple Sclerosis and Age at Infection with Common Viruses
Hernán, M. Á., Zhang, S. M., Lipworth, L. P., Olek, M. J., & Ascherio, A. (2001) · Epidemiology · doi:10.1097/00001648-200105000-00009 · Cited by 158
New diagnostic criteria for multiple sclerosis
Petereit, H. F., & Heiss, W. (2002) · Annals of Neurology · doi:10.1002/ana.10152 · Cited by 140
Epstein‐Barr nuclear antigen and viral capsid antigen antibody titers in multiple sclerosis
Larsen, P. D., Bloomer, L. C., & Bray, P. F. (1985) · Neurology · doi:10.1212/wnl.35.3.435 · Cited by 138
Sitki‐Green, D., Covington, M., & Raab‐Traub, N. (2003) · Journal of Virology · doi:10.1128/jvi.77.3.1840-1847.2003 · Cited by 137
Multisequence MRI in clinically isolated syndromes and the early development of MS
Brex, P., O’Riordan, J. I., Miszkiel, K., MOSELEY, I. F., Thompson, A. J., Plant, G. T., & Miller, D. H. (1999) · Neurology · doi:10.1212/wnl.53.6.1184 · Cited by 116
Evans, A. S., & Niederman, J. C. (1982) · Springer eBooks · doi:10.1007/978-1-4613-3237-4_10 · Cited by 104
Herpesvirus and multiple sclerosis.
Simmons, A. (2001) · PubMed · Cited by 103
Lennette, E. T., Rymo, L., Yadav, M., Masucci, G. V., Merk, K., Tı́már, L., & Klein, G. (1993) · European Journal of Cancer · doi:10.1016/0959-8049(93)90299-u · Cited by 65
Cited by
Bjornevik, K., Cortese, M., Healy, B. C., Kuhle, J., Mina, M. J., Leng, Y., Elledge, S. J., Niebuhr, D. W., Scher, A. I., Munger, K. L., et al. (2022) · Science · doi:10.1126/science.abj8222 · Cited by 2,049
Serum 25-Hydroxyvitamin D Levels and Risk of Multiple Sclerosis
Munger, K. L., Levin, L. I., Hollis, B. W., Howard, N. S., & Ascherio, A. (2006) · JAMA · doi:10.1001/jama.296.23.2832 · Cited by 1,897
Self-citationThompson, A. J., Baranzini, S. E., Geurts, J., Hemmer, B., & Ciccarelli, O. (2018) · The Lancet · doi:10.1016/s0140-6736(18)30481-1 · Cited by 1,797
Interactions between genetic, lifestyle and environmental risk factors for multiple sclerosis
Olsson, T., Barcellos, L. F., & Alfredsson, L. (2017) · Nature Reviews Neurology · doi:10.1038/nrneurol.2016.187 · Cited by 1,185
Environmental risk factors for multiple sclerosis. Part I: The role of infection
Ascherio, A., & Munger, K. L. (2007) · Annals of Neurology · doi:10.1002/ana.21117 · Cited by 1,042
Metadata
- Authors
- Levin, L. I.
- Venue
- JAMA
- Publisher
- American Medical Association (AMA)
- Published
- 2005-05-25
- Volume
- 293
- Issue
- 20
- Pages
- 2496
- ISSN
- 0002-9955 (ISSN-L)
- 0098-7484
- OpenAlex
- W2078229430
- Cited by
- 448
- References
- 27
- FWCI
- 15.20
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.